Structured evidence table for Protein Intake Resistance Training Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Protein Intake Resistance Training Meta-Analysis | Effects of Physical Exercise with and Without Nutritional Supplementation on Serum Albumin in Older People: A Systematic Review and Meta-Analysis | 1 | Aravena-Sagardia P (2026) | Effects of Physical Exercise with and Without Nutritional Supplementation on Serum Albumin in Older People: A Systematic Review and Meta-Analysis |
| Protein Intake Resistance Training Meta-Analysis | Randomized clinical trials consistently report mean weight loss ranging from approximately 15% to more than 20% of total body weight, accompanied by improvements in glycemic control, cardiometabolic risk factors, and obesity-related comorbidities [,,]. | 3 | Zambrano-Villacres Raynier (2026) | Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance |
| Protein Intake Resistance Training Meta-Analysis | As a result, pharmacotherapy is increasingly positioned as an important component of contemporary obesity treatment algorithms rather than a secondary or last-line option []. | 3 | Zambrano-Villacres Raynier (2026) | Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance |
| Protein Intake Resistance Training Meta-Analysis | 20 20 20 21 22 23 24 25 26 Emerging real-world evidence indicates that a substantial proportion of individuals initiating GLP-1 receptor agonist therapy discontinue treatment within the first year []. | 3 | Zambrano-Villacres Raynier (2026) | Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance |
| Protein Intake Resistance Training Meta-Analysis | 1 2 3 4 5 6 7 8 9 The therapeutic landscape of obesity management has changed profoundly with the clinical introduction and rapid uptake of glucagon-like peptide-1 (GLP-1) receptor agonists and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GLP-1RAs) [,]. | 3 | Zambrano-Villacres Raynier (2026) | Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance |
Source documents